• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉输注P物质对正常男性精氨酸加压素和催产素分泌的影响。

Effects of intravenous infusion of substance P on arginine vasopressin and oxytocin secretion in normal men.

作者信息

Chiodera P, Coiro V

机构信息

Department of Internal Medicine, School of Medicine, University of Parma, Italy.

出版信息

Brain Res. 1992 Jan 8;569(1):173-6. doi: 10.1016/0006-8993(92)90387-o.

DOI:10.1016/0006-8993(92)90387-o
PMID:1377080
Abstract

In order to establish possible stimulatory effects of increasing plasma concentrations of substance P (SP) on the arginine vasopressin (AVP) and/or oxytocin (OT) secretion, successively increasing doses of SP(0.5, 1 and 1.5 pmol/kg-1/min-1; each dose for 20 min) were infused in 7 normal men. Plasma AVP and OT levels were measured before infusion and every 20 min, just before increasing the infusion dose of SP. During tests, SP infusion did not produce untoward side effects or changes in blood osmolality and/or pressure. Plasma OT levels did not change during SP infusion. Plasma AVP concentrations were not modified by the infusion of the lowest dose of SP, whereas they were significantly increased in a dose response fashion when higher amounts of SP were given. These findings demonstrate for the first time in humans that the systemic administration of SP exerts stimulatory effects on AVP, but not on OT secretion.

摘要

为了确定血浆中P物质(SP)浓度升高对精氨酸加压素(AVP)和/或催产素(OT)分泌可能产生的刺激作用,对7名正常男性连续输注递增剂量的SP(0.5、1和1.5 pmol/kg-1/min-1;每个剂量持续20分钟)。在输注前以及每次增加SP输注剂量前20分钟测量血浆AVP和OT水平。测试期间,SP输注未产生不良反应,也未引起血液渗透压和/或血压变化。SP输注期间血浆OT水平未改变。输注最低剂量的SP时,血浆AVP浓度未改变,而给予更高剂量的SP时,血浆AVP浓度呈剂量反应方式显著升高。这些发现首次在人体中证明,全身性给予SP对AVP分泌有刺激作用,但对OT分泌无刺激作用。

相似文献

1
Effects of intravenous infusion of substance P on arginine vasopressin and oxytocin secretion in normal men.静脉输注P物质对正常男性精氨酸加压素和催产素分泌的影响。
Brain Res. 1992 Jan 8;569(1):173-6. doi: 10.1016/0006-8993(92)90387-o.
2
Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on arginine vasopressin and oxytocin secretion in man.
Neuroreport. 1995 Jul 31;6(11):1490-2. doi: 10.1097/00001756-199507310-00006.
3
Arginine vasopressin and oxytocin responses to angiotensin II are mediated by AT1 receptor subtype in normal men.
Metabolism. 1998 Aug;47(8):893-6. doi: 10.1016/s0026-0495(98)90339-0.
4
Effect of chronic hyponatremia on central and peripheral oxytocin and vasopressin secretion in rats.慢性低钠血症对大鼠中枢和外周催产素及血管升压素分泌的影响。
Neuroendocrinology. 1995 Apr;61(4):412-20. doi: 10.1159/000126863.
5
Naloxone increases the angiotensin II stimulated rise of arginine vasopressin and oxytocin secretion in man.
Neuroendocrinology. 1991 Mar;53(3):209-13. doi: 10.1159/000125720.
6
Luteinizing hormone response to an intravenous infusion of substance P in normal men.
Metabolism. 1992 Jul;41(7):689-91. doi: 10.1016/0026-0495(92)90305-t.
7
Preferential release of oxytocin in response to vasoactive intestinal polypeptide in rats.大鼠体内血管活性肠肽作用下催产素的优先释放
Life Sci. 1987 Jan 12;40(2):169-73. doi: 10.1016/0024-3205(87)90356-0.
8
Opioid-mediated inhibition of oxytocin during insulin-induced hypoglycemic stimulation of vasopressin in man.在人体胰岛素诱导的低血糖刺激血管加压素过程中,阿片类物质介导的催产素抑制作用。
Acta Endocrinol (Copenh). 1988 May;118(1):77-81. doi: 10.1530/acta.0.1180077.
9
Vasopressin and oxytocin responses to acute and chronic osmotic stimuli in man.
J Endocrinol. 1986 Jan;108(1):163-8. doi: 10.1677/joe.0.1080163.
10
Release of oxytocin and vasopressin by intracerebroventricular vasoactive intestinal polypeptide.脑室内血管活性肠肽释放催产素和加压素。
Endocrinology. 1988 Nov;123(5):2249-54. doi: 10.1210/endo-123-5-2249.

引用本文的文献

1
Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.精神病学中的P物质受体拮抗剂:开发原理与治疗潜力
CNS Drugs. 2005;19(4):275-93. doi: 10.2165/00023210-200519040-00001.